GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
06 May 2020 05:40 PM
RNS
Result of AGM
04 May 2020 06:00 PM
RNS
Director/PDMR Shareholding
04 May 2020 05:40 PM
RNS
Publication of a Prospectus
04 May 2020 04:18 PM
RNS
Rights attached to ordinary shares
01 May 2020 03:45 PM
RNS
Total Voting Rights
30 Apr 2020 07:00 AM
RNS
GSK's Zejula approved in first-line ovarian cancer
29 Apr 2020 12:00 PM
RNS
1st Quarter Results
29 Apr 2020 11:00 AM
RNS
Arrangements for Shareholder Webcast
16 Apr 2020 03:25 PM
RNS
Director/PDMR Shareholding
16 Apr 2020 02:21 PM
RNS
Director/PDMR Shareholding
16 Apr 2020 01:49 PM
RNS
Director/PDMR Shareholding
14 Apr 2020 04:35 PM
RNS
Director/PDMR Shareholding
14 Apr 2020 04:31 PM
RNS
Director/PDMR Shareholding
14 Apr 2020 03:09 PM
RNS
Director/PDMR Shareholding
14 Apr 2020 12:00 PM
RNS
Sanofi and GSK collaboration to fight COVID-19
09 Apr 2020 11:52 AM
RNS
AGM - Change of Arrangements
06 Apr 2020 01:00 PM
RNS
GSK and Vir Biotechnology enter collaboration
01 Apr 2020 12:57 PM
RNS
GSK completes divestment of Horlicks
01 Apr 2020 11:11 AM
RNS
Total Voting Rights
30 Mar 2020 04:06 PM
RNS
Consumer Healthcare product sales category changes
25 Mar 2020 04:42 PM
RNS
Second Price Monitoring Extn
25 Mar 2020 04:37 PM
RNS
Price Monitoring Extension
24 Mar 2020 04:40 PM
RNS
Second Price Monitoring Extn
24 Mar 2020 04:35 PM
RNS
Price Monitoring Extension
24 Mar 2020 07:00 AM
RNS
Publication of AGM Notice
20 Mar 2020 02:00 PM
RNS
Directorate Change
18 Mar 2020 12:20 PM
RNS
Director/PDMR Shareholding
13 Mar 2020 05:24 PM
RNS
EMTN Prospectus Supplement Update
11 Mar 2020 05:00 PM
RNS
Director/PDMR Shareholding
09 Mar 2020 04:15 PM
RNS
Director/PDMR Shareholding
09 Mar 2020 07:00 AM
RNS
Publication of GSK 2019 Form 20-F
04 Mar 2020 02:53 PM
RNS
Annual Financial Report
02 Mar 2020 11:00 AM
RNS
Total Voting Rights
21 Feb 2020 01:00 PM
RNS
Director/PDMR Shareholding
20 Feb 2020 03:30 PM
RNS
Director/PDMR Shareholding
20 Feb 2020 02:00 PM
RNS
Director/PDMR Shareholding
20 Feb 2020 02:00 PM
RNS
Director/PDMR Shareholding
19 Feb 2020 05:25 PM
RNS
Director/PDMR Shareholding
19 Feb 2020 04:35 PM
RNS
Director/PDMR Shareholding
19 Feb 2020 04:28 PM
RNS
Director/PDMR Shareholding
19 Feb 2020 04:24 PM
RNS
Director/PDMR Shareholding
19 Feb 2020 04:17 PM
RNS
Director/PDMR Shareholding
12 Feb 2020 05:05 PM
RNS
Director/PDMR Shareholding
11 Feb 2020 02:15 PM
RNS
Director/PDMR Shareholding
11 Feb 2020 07:00 AM
RNS
Transfer of Treasury Shares
06 Feb 2020 04:00 PM
RNS
Director/PDMR Shareholding
05 Feb 2020 04:15 PM
RNS
Director/PDMR Shareholding
05 Feb 2020 12:00 PM
RNS
Final Results
03 Feb 2020 03:15 PM
RNS
GSK publishes provisional 2020 Dividend Dates
03 Feb 2020 09:30 AM
RNS
Total Voting Rights

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

GSK share price launched at 346p in 1989. 

UK 100

Latest directors dealings